SNCA mutation p.Ala53Glu is derived from a common founder in the Finnish population

Neurobiol Aging. 2017 Feb:50:168.e5-168.e8. doi: 10.1016/j.neurobiolaging.2016.10.014. Epub 2016 Oct 19.

Abstract

Mutations in SNCA are rare causes of familial Parkinson's disease (PD). We have previously described a novel p.Ala53Glu mutation in 2 Finnish families. To assess this mutation's frequency among Finnish PD patients, we screened 110 PD patients (mean age-of-onset 60 years) from Western Finland by Sanger sequencing of the third coding exon of SNCA. In addition, a sample of 47 PD subjects (mean age-of-onset 53 years) originating from Southern and Eastern Finland were studied using next-generation sequencing covering SNCA. Only one new individual with the p.Ala53Glu mutation was identified, confirming that this mutation is a rare cause of PD in the Finnish population. To search for a possible common origin of the p.Ala53Glu mutation, haplotype analysis was conducted in 2 families and in a patient from a third family (6 affected subjects) using both STR markers and a genome-wide SNP array. The results show that patients with the p.Ala53Glu mutation share a haplotype spanning a minimum of 5.7 Mb suggesting a common founder.

Keywords: A53E; Founder effect; Haplotype; SNCA.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Exons / genetics
  • Female
  • Finland
  • Founder Effect*
  • Genetic Association Studies*
  • Haplotypes / genetics
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Parkinson Disease / genetics*
  • White People / genetics
  • alpha-Synuclein / genetics*

Substances

  • SNCA protein, human
  • alpha-Synuclein